IBB

Fund Description
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of companies primarily engaged in the biotechnology industry as represented by the NASDAQ Biotechnology Index .
Fund Profile
Fund Name iShares Nasdaq Biotechnology ETF
Fund Exchange Ticker IBB
Fund Sponsor Blackrock (iShares)
Fund ISIN US4642875565
Net Expense Ratio 0.46 %
Fund Inception Date 5 February 2001
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name NASDAQ Biotechnology Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 30 October 2020
Asset Under Management 8760.60 Million (USD)
1 Month Total Return -4.43 %
Year To Date Return 8.61 %
1 Year Total Return 21.99 %
3 Year Annualized Total Return 7.60 %
NAV 130.366
Share Outstanding 67,200,000
Top 10 Holdings (29 October 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
GILEAD SCIENCES INC GILD EQUI 0.0737000000
AMGEN INC AMGN EQUI 0.0723000000
REGENERON PHARMACEUTICALS REGN EQUI 0.0631000000
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0586000000
ILLUMINA INC ILMN EQUI 0.0499000000
SEAGEN INC SGEN EQUI 0.0368000000
BIOGEN INC BIIB EQUI 0.0359000000
MODERNA INC MRNA EQUI 0.0309000000
ALEXION PHARMACEUTICALS INC ALXN EQUI 0.0285000000
INCYTE CORP INCY EQUI 0.0209000000